Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties.

Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride) (PVM/MA) were prepared by simple solvent displacement method, in the absence of catalysts or specific chemical conditions. Pegylation efficiency increased with the increasing of molecular weight and bulk concentration of poly(ethylene glycols) (PEGs) investigated. In fact, the use of PEG with molecular weight less than 1000 Da did not lead to its attachment. 1H NMR spectroscopy was performed in order to estimate the conformation state of PEG-chains and to predict the nanoparticle structure. Pegylation with PEG 2000 gave surface modified nanoparticles ("brush" conformation), while the chains of PEG 1000 were distributed either in the core or physically adsorbed on the nanoparticle surface. The capacity of nanoparticles to adsorb mucin at pH 7.4 was significantly higher for PEG 1000-NP than for PEG 2000-NP. The "brush" layer seemed to decrease the interaction between PEG 2000-NP and mucin, which facilitated their penetration through the mucus gel. As a consequence, PEG 2000-NP displayed higher capacity to develop adhesive interactions with rat intestinal mucosa in vivo. Independent on the weaker bioadhesive potential of PEG 1000-NP, both types of pegylated nanoparticles demonstrated very high affinity to the intestinal mucosa rather than to the stomach wall, which could be established for drug targeting to the small intestine.

[1]  C. Pichot,et al.  Covalent immobilization of biological molecules to maleic anhydride and methyl vinyl ether copolymers : A physico-chemical approach , 1999 .

[2]  J. Feijen,et al.  Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.

[3]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[4]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[5]  I. Colombo,et al.  Investigation of surface properties of some polymers by a thermodynamic and mechanical approach: possibility of predicting mucoadhesion and biocompatibility. , 1994, Biomaterials.

[6]  A. Vila,et al.  Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[7]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[8]  V. Torchilin Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[9]  M. A. Arangoa,et al.  Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. , 2002, International journal of pharmaceutics.

[10]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[11]  J. Robinson,et al.  Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.

[12]  W. Saltzman,et al.  Synthetic polymers alter the structure of cervical mucus. , 2001, Biomaterials.

[13]  S. Yamashita,et al.  Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract , 1997 .

[14]  G. Halbert,et al.  The in Vitro Cell Association of Invasin Coated Polylactide-Co-glycolide Nanoparticles , 2000, Pharmaceutical Research.

[15]  P. Dubin,et al.  Hydrophobic hypercoiling in copolymers of maleic acid and alkyl vinyl ethers , 1967 .

[16]  N Hussain,et al.  Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. , 2001, Advanced drug delivery reviews.

[17]  M. Wirth,et al.  Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Gilles Ponchel,et al.  Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics , 2001, Pharmaceutical Research.

[19]  T. Kissel,et al.  Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  G. Russell-Jones,et al.  Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. , 1999, International journal of pharmaceutics.

[21]  Alexander T. Florence,et al.  Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.

[22]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[23]  Soriano,et al.  The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. , 2000, Colloids and surfaces. B, Biointerfaces.

[24]  Ji Qian,et al.  Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. , 2004, World journal of gastroenterology.

[25]  J. Demeester,et al.  Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus , 2002, Gene Therapy.

[26]  O. Bourdon,et al.  Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.

[27]  Y. Huang,et al.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[28]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[29]  E. Schacht,et al.  In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. , 1998, Journal of pharmaceutical sciences.

[30]  C. Pichot,et al.  Covalent immobilization of bovine serum albumin onto (maleic anhydride-alt-methyl vinyl ether) copolymers , 1999 .

[31]  M. Alonso,et al.  Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration , 1998, Pharmaceutical Research.